Cited by 302Genetic factors in colorectal cancerEpigenetics and DNA MethylationColorectal Cancer Treatments and Studies

The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.

Frequent Inactivation of PTEN by Promoter Hypermethylation in Microsatellite Instability-High Sporadic Colorectal Cancers

Goel, Ajay, Arnold, Christian N., Niedzwiecki, Donna, Carethers, John M., Dowell, Jeannette M., Wasserman, Linda, Compton, Carolyn, Mayer, Robert J., Bertagnolli, Monica M., Boland, C. Richard·2004·Cancer Research

DOI 10.1158/0008-5472.can-2401-2

Open this paper in CoChat — free account

Abstract

Loss of PTEN tumor suppressor function is observed in tumors of breast, prostate, thyroid, and endometrial origin. Allelic losses in the proximity of the PTEN locus (10q23) also occur in sporadic colorectal cancers (CRCs), but biallelic inactivation of this site has not been frequently demonstrated. We hypothesized that alternative mechanisms of PTEN allelic inactivation, such as promoter hypermethylation, might be operative in CRC and that PTEN inactivation may be related to recognized forms of genomic instability. We characterized a cohort of 273 sporadic CRCs by determining their microsatellite instability (MSI) status. Of these, 146 cancers were examined for PTEN promoter methylation by methylation-specific PCR. Mutations at the poly(A)6 repeat sequences in PTEN exons 7 and 8 and deletions at the 10q23 locus were also identified using microsatellite analysis. The presence of PTEN protein was determined by immunostaining, and the results were correlated with the promoter methylation status. We observed that PTEN promoter hypermethylation was a frequent occurrence in MSI-high (MSI-H) tumors (19.1% of MSI-H versus 2.2% of MSI-low/microsatellite stable tumors; P = 0.002). A PTEN mutation or a deletion event was present in 60% of the tumors with promoter region hypermethylation. Hypermethylation of the PTEN promoter correlated significantly with either decreased or complete loss of PTEN protein expression (P = 0.004). This is the first demonstration of PTEN inactivation as a result of promoter hypermethylation in MSI-H sporadic CRCs. These data suggest that this silencing mechanism plays a major role in PTEN inactivation and, in colon cancer, may be more important than either allelic losses or inactivating mutations. The significant correlation of PTEN hypermethylation with MSI-H tumors further suggests that PTEN is an additional important “target” of methylation along with the hMLH1 gene in the evolution of MSI-H CRCs and also confers the “second hit” in the biallelic inactivation mechanism for some proportion of tumors.

Integrity signals

Registry

Crossref · 10.1158/0008-5472.can-2401-2

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.
Herman, J. G., Graff, J. R., Myöhänen, S., Nelkin, B. D., & Baylin, S. B. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.18.9821 · Cited by 5,634
PTEN , a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate Cancer
Li, J., Yen, C., Liaw, D., Podsypanina, K., Bose, S., Wang, S. I., Puc, J., Miliaresis, C., Rodgers, L., McCombie, R., et al. (1997) · Science · doi:10.1126/science.275.5308.1943 · Cited by 4,785
A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer.
Boland, C. R., Thibodeau, S. N., Hamilton, S. R., Sidransky, D., Eshleman, J. R., Burt, R. W., Meltzer, S. J., Rodrı́guez-Bigas, M. A., Fodde, R., Ranzani, G. N., et al. (1998) · PubMed · Cited by 4,087
Self-citation
Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers
Steck, P. A., Pershouse, M. A., Jasser, S. A., Yung, W. K. A., Lin, H., Ligon, A. H., Langford, L. A., Baumgard, M. L., Hattier, T., Davis, T., et al. (1997) · Nature Genetics · doi:10.1038/ng0497-356 · Cited by 2,742
The Multiple Roles of PTEN in Tumor Suppression
Di Cristofano, A., & Pandolfi, P. P. (2000) · Cell · doi:10.1016/s0092-8674(00)80674-1 · Cited by 1,182
Crystal Structure of the PTEN Tumor Suppressor
Lee, J., Yang, H., Georgescu, M.-M., Cristofano, A. D., Maehama, T., Shi, Y., Dixon, J. E., Pandolfi, P. P., & Pavletich, N. P. (1999) · Cell · doi:10.1016/s0092-8674(00)81663-3 · Cited by 1,032
Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability.
Cunningham, J. M., Christensen, E. R., Tester, D. J., Kim, C. Y., Roche, P. C., Burgart, L. J., & Thibodeau, S. N. (1998) · PubMed · Cited by 863
Inactivation of the tumor suppressor PTEN/MMAC1 in advanced human prostate cancer through loss of expression
Whang, Y. E., Wu, X., Suzuki, H., Reiter, R. E., Tran, C., Vessella, R. L., SAID, J. W., Isaacs, W. B., & Sawyers, C. L. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.9.5246 · Cited by 639
PTEN: a tumour suppressor that functions as a phospholipid phosphatase
Maehama, T. (1999) · Trends in Cell Biology · doi:10.1016/s0962-8924(99)01519-6 · Cited by 599
PTEN/MMAC1 mutations in endometrial cancers.
Risinger, J. I., Hayes, A. K., Berchuck, A., & Barrett, J. C. (1997) · PubMed · Cited by 509

Show all 35 references

Sorted by citations

Items 101–200 of 302

Markers of resistance to anti-EGFR therapy in colorectal cancer.
Shaib, W. L., Mahajan, R., & El‐Rayes, B. F. (2013) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2078-6891.2013.029 · Cited by 61
Comprehensive characterization of PTEN mutational profile in a series of 34,129 colorectal cancers
Serebriiskii, I. G., Pavlov, V., Tricarico, R., Andrianov, G., Nicolas, E., Parker, M. I., Newberg, J., Frampton, G., Meyer, J. E., & Golemis, E. A. (2022) · Nature Communications · doi:10.1038/s41467-022-29227-2 · Cited by 55
Curcumin: A therapeutic strategy for colorectal cancer?
de Porras, V. R., Layos, L., & Martinez‐Balibrea, E. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.09.004 · Cited by 58
New phosphatidylinositol 3-kinase inhibitors for cancer
Bowles, D. W., & Jimeno, A. (2011) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2011.562192 · Cited by 54
microRNA-181a is associated with poor prognosis of colorectal cancer
Nishimura, J., Handa, R., Yamamoto, H., Tanaka, F., Shibata, K., Mimori, K., Takemasa, I., Mizushima, T., Ikeda, M., Sekimoto, M., et al. (2012) · Oncology Reports · doi:10.3892/or.2012.2059 · Cited by 54
Fibroblast-derived CXCL12 regulates PTEN expression and is associated with the proliferation and invasion of colon cancer cells via PI3k/Akt signaling
Ma, J., Sun, X., Wang, Y., Chen, B., Qian, L., & Wang, Y. (2019) · Cell Communication and Signaling · doi:10.1186/s12964-019-0432-5 · Cited by 54
Chronic Inflammation and Cancer: Key Pathways and Targeted Therapies
Kapoor, G., Prakash, S., Jaiswal, V. P., & Singh, A. K. (2024) · Cancer Investigation · doi:10.1080/07357907.2024.2437614 · Cited by 60
MicroRNA-498 promotes proliferation and migration by targeting the tumor suppressor PTEN in breast cancer cells
Chai, C., Wu, H., Wang, B., Eisenstat, D. D., & Leng, R. P. (2018) · Carcinogenesis · doi:10.1093/carcin/bgy092 · Cited by 53
PTEN loss and KRAS activation leads to the formation of serrated adenomas and metastatic carcinoma in the mouse intestine
Davies, E. J., Durban, V. M., Méniel, V. S., Williams, G. T., & Clarke, A. R. (2013) · The Journal of Pathology · doi:10.1002/path.4312 · Cited by 54
Trichilemmomas show loss of PTEN in Cowden syndrome but only rarely in sporadic tumors
Al-Zaid, T. J., Ditelberg, J. S., Prieto, V. G., Lev, D. C., Luthra, R., Davies, M. A., Diwan, A. H., Wang, W., & Lazar, A. J. (2012) · Journal of Cutaneous Pathology · doi:10.1111/j.1600-0560.2012.01888.x · Cited by 52
Molecular Pathogenesis and Classification of Colorectal Carcinoma
Kasi, A., Handa, S., Bhatti, S. A., Umar, S., Bansal, A. K., & Sun, W. (2020) · Current Colorectal Cancer Reports · doi:10.1007/s11888-020-00458-z · Cited by 56
Optimization of a pentaplex panel for MSI analysis without control DNA in a Brazilian population: correlation with ancestry markers
Campanella, N. C., Berardinelli, G. N., Scapulatempo‐Neto, C., Viana, D. D. A., Palmero, E. I., Pereira, R., & Reis, R. M. (2013) · European Journal of Human Genetics · doi:10.1038/ejhg.2013.256 · Cited by 50
The PI3K/Akt/mTOR axis in colorectal cancer: Oncogenic alterations, non‐coding RNAs, therapeutic opportunities, and the emerging role of nanoparticles
Sanaei, M., Khorasani, A. B. S., Pourbagheri‐Sigaroodi, A., Shahrokh, S., Zali, M. R., & Bashash, D. (2021) · Journal of Cellular Physiology · doi:10.1002/jcp.30655 · Cited by 57
Piwil1 causes epigenetic alteration of PTEN gene via upregulation of DNA methyltransferase in type I endometrial cancer
Chen, Z., Che, Q., Jiang, F., Wang, H., Wang, F., Liao, Y. J., & Wan, X. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.06.028 · Cited by 50
PTEN expression is consistent in colorectal cancer primaries and metastases and associates with patient survival
Atreya, C. E., Sangale, Z., Xu, N., Matli, M. R., Tikishvili, E., Welbourn, W., Stone, S., Shokat, K. M., & Warren, R. S. (2013) · Cancer Medicine · doi:10.1002/cam4.97 · Cited by 52
Obesity-Associated Colorectal Cancer
Gonzalez-Gutierrez, L., Motiño, O., Barriuso, D., de la Puente-Aldea, J., Alvarez-Frutos, L., Kroemer, G., Palacios, R., & Senovilla, L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25168836 · Cited by 55
Multi-Scale Genomic, Transcriptomic and Proteomic Analysis of Colorectal Cancer Cell Lines to Identify Novel Biomarkers
Briffa, R., Um, I. H., Faratian, D., Zhou, Y. Y., Turnbull, A., Langdon, S. P., & Harrison, D. J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0144708 · Cited by 51
Indole-3-Carbinol Prevents PTEN Loss in Cervical Cancer In Vivo
Qi, M., Anderson, A., Chen, D.-Z., Sun, S., & Auborn, K. (2005) · Molecular Medicine · doi:10.2119/2006-00007.auborn · Cited by 51
Immunotherapy in human colorectal cancer: Challenges and prospective
Sun, X., Suo, J., & Yan, J. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i28.6362 · Cited by 50
Distinct mutational profile and immune microenvironment in microsatellite-unstable and POLE-mutated tumors
Hwang, H. S., Kim, D., & Choi, J. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-002797 · Cited by 47
A comprehensive analysis of phosphatase and tensin homolog deleted on chromosome 10 (PTEN) loss in colorectal cancer
Lin, P.-C., Lin, J.-K., Lin, H., Lan, Y., Lin, C., Yang, S.-H., Chen, W.-S., Liang, W.-Y., Jiang, J., & Chang, S. (2015) · World Journal of Surgical Oncology · doi:10.1186/s12957-015-0601-y · Cited by 44
RAB32 hypermethylation and microsatellite instability in gastric and endometrial adenocarcinomas
Shibata, D., Mori, Y., Cai, K., Zhang, L., Yin, J., Elahi, A. H., Hamelin, R., Wong, Y. F., Lo, W. K., Chung, T. K. H., et al. (2006) · International Journal of Cancer · doi:10.1002/ijc.21912 · Cited by 44
CRISPR-Cas System: The Current and Emerging Translational Landscape
Bhokisham, N., Laudermilch, E., Traeger, L. L., Bonilla, T. D., Ruíz-Estévez, M., & Becker, J. R. (2023) · Cells · doi:10.3390/cells12081103 · Cited by 46
Beyond KRAS: Predictive factors of the efficacy of anti-EGFR monoclonal antibodies in the treatment of metastatic colorectal cancer
Stefano, A. D. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i29.9732 · Cited by 45
The prognostic effect of PTEN expression status in colorectal cancer development and evaluation of factors affecting it: miR-21 and promoter methylation
Yazdani, Y., Farazmandfar, T., Azadeh, H., & Zekavatian, Z. (2016) · Journal of Biomedical Science · doi:10.1186/s12929-016-0228-5 · Cited by 45
Potential predictive markers of response to EGFR-targeted therapies in colorectal cancer
Spano, J., Milano, G. A., Vignot, S., & Khayat, D. (2008) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2007.11.005 · Cited by 44
PTEN expression profiles in colorectal adenocarcinoma and its precancerous lesions
Waniczek, D., Śnietura, M., Młynarczyk-Liszka, J., Pigłowski, W., Kopeć, A., Lange, D., Rudzki, M., & Arendt, J. (2013) · Polish Journal of Pathology · doi:10.5114/pjp.2013.34598 · Cited by 42
LOH at 6q and 10q in fractionated circulating DNA of ovarian cancer patients is predictive for tumor cell spread and overall survival
Kuhlmann, J. D., Schwarzenbach, H., Wimberger, P., Poetsch, M., Kimmig, R., & Kasimir‐Bauer, S. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-325 · Cited by 42
Human Colorectal Cancer from the Perspective of Mouse Models
Šťastná, M., Janečková, L., Hrčkulák, D., Kříž, V., & Kořínek, V. (2019) · Genes · doi:10.3390/genes10100788 · Cited by 43
Phosphatidylinositol‐3‐kinase pathway aberrations in gastric and colorectal cancer: Meta‐analysis, co‐occurrence and ethnic variation
Chong, M. L., Loh, M. C. S., Thakkar, B. M., Pang, B., Iacopetta, B. J., & Soong, R. (2013) · International Journal of Cancer · doi:10.1002/ijc.28444 · Cited by 40
Resistance to Imatinib Mesylate-induced apoptosis in acute lymphoblastic leukemia is associated with PTEN down-regulation due to promoter hypermethylation
Montiel‐Duarte, C., Cordeu, L., Agirre, X., Román‐Gómez, J., Jiménez‐Velasco, A., José‐Eneriz, E. S., Gárate, L., Andreu, E. J., Calasanz, M. J., Heiniger, A., et al. (2008) · Leukemia Research · doi:10.1016/j.leukres.2007.09.005 · Cited by 40
Molecular targeting in the treatment of either advanced or metastatic bladder cancer or both according to the signalling pathways
Wallerand, H., Reiter, R. E., & Ravaud, A. (2008) · Current Opinion in Urology · doi:10.1097/mou.0b013e3283097889 · Cited by 39
A Colon Cancer-derived Mutant of Krüppel-like Factor 5 (KLF5) Is Resistant to Degradation by Glycogen Synthase Kinase 3β (GSK3β) and the E3 Ubiquitin Ligase F-box and WD Repeat Domain-containing 7α (FBW7α)
Bialkowska, A. B., Liu, Y., Nandan, M. O., & Yang, V. W. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.508549 · Cited by 39
High Throughput Screen Identifies the DNMT1 (DNA Methyltransferase-1) Inhibitor, 5-Azacytidine, as a Potent Inducer of PTEN (Phosphatase and Tensin Homolog)
Strand, K. A., Lu, S., Mutryn, M. F., Li, L., Zhou, Q., Enyart, B. T., Jolly, A., Dubner, A., Moulton, K. S., Nemenoff, R. A., et al. (2020) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.120.314458 · Cited by 38
Genomic landscape of colorectal carcinogenesis
Kim, J. C., & Bodmer, W. F. (2022) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-021-03888-w · Cited by 37
RES-529
Weinberg, M. A. (2016) · Anti-Cancer Drugs · doi:10.1097/cad.0000000000000354 · Cited by 36
CDC73/HRPT2 CpG island hypermethylation and mutation of 5′-untranslated sequence are uncommon mechanisms of silencing parafibromin in parathyroid tumors
Hahn, M. A., Howell, V. M., Gill, A. J., Clarkson, A., Weaire‐Buchanan, G., Robinson, B. G., Delbridge, L., Gimm, O., Schmitt, W., Teh, B. T., et al. (2009) · Endocrine Related Cancer · doi:10.1677/erc-09-0291 · Cited by 35
TGF-β1 Signalling, Connecting Aberrant Inflammation and Colorectal Tumorigenesis
Skeen, V. R., Paterson, I. C., Paraskeva, C., & Williams, A. C. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212802083734 · Cited by 35
PTEN and p16 genes as epigenetic biomarkers in oral squamous cell carcinoma (OSCC): a study on south Indian population
Sushma, P. S., Jamil, K., Kumar, P. U., Satyanarayana, U., Ramakrishna, M., & Triveni, B. (2015) · Tumor Biology · doi:10.1007/s13277-015-4648-8 · Cited by 36
Metastasis-associated Protein 1/Histone Deacetylase 4-Nucleosome Remodeling and Deacetylase Complex Regulates Phosphatase and Tensin Homolog Gene Expression and Function
Reddy, S. D. N., Pakala, S. B., Molli, P. R., Sahni, N., Karanam, N. K., Mudvari, P., & Kumar, R. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.348474 · Cited by 34
Molecularly targeted agents: Their promise as cancer chemopreventive interventions
Thiery-Vuillemin, A., Nguyen, T., Pivot, X. B., Spano, J., Dufresnne, A., & Soria, J. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.06.005 · Cited by 34
Cellular and molecular events in colorectal cancer: biological mechanisms, cell death pathways, drug resistance and signalling network interactions
Yan, L., Shi, J. H., & Zhu, J. (2024) · Discover Oncology · doi:10.1007/s12672-024-01163-1 · Cited by 39
Synergistic activity of everolimus and 5‐aza‐2′‐deoxycytidine in medullary thyroid carcinoma cell lines
Vitale, G., Dicitore, A., Pepe, D., Gentilini, D., Grassi, E., Borghi, M. O., Gelmini, G., Cantone, M. C., Gaudenzi, G., Misso, G., et al. (2017) · Molecular Oncology · doi:10.1002/1878-0261.12070 · Cited by 35
Epidermal Growth Factor Receptor Pathway Mutations and Colorectal Cancer Therapy
Grossmann, A. H., & Samowitz, W. S. (2011) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2011-0047-ra · Cited by 33
TGFβ modulates PTEN expression independently of SMAD signaling for growth proliferation in colon cancer cells
Chow, J. Y. C., Cabral, J., Chang, J. K., & Carethers, J. M. (2008) · Cancer Biology & Therapy · doi:10.4161/cbt.7.10.6665 · Cited by 32
Self-citation
The association of PTEN hypermethylation and breast cancer: a meta-analysis
Luo, S., Chen, J., & Mo, X. (2016) · OncoTargets and Therapy · doi:10.2147/ott.s111684 · Cited by 32
The Mechanisms Underlying PTEN Loss in Human Tumors Suggest Potential Therapeutic Opportunities
Chang, H., Cai, Z., & Roberts, T. (2019) · Biomolecules · doi:10.3390/biom9110713 · Cited by 30
Predicting response to epidermal growth factor receptor-targeted therapy in colorectal cancer
Adams, R., & Maughan, T. (2007) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.7.4.503 · Cited by 32
Developing gene expression signatures of pathway deregulation in tumors
Watters, J., & Roberts, C. J. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0340 · Cited by 32
PTEN, PTENP1, microRNAs, and ceRNA Networks: Precision Targeting in Cancer Therapeutics
Travis, G., McGowan, E. M., Simpson, A. M., Marsh, D. J., & Nassif, N. T. (2023) · Cancers · doi:10.3390/cancers15204954 · Cited by 31
Integrated molecular dissection of the epidermal growth factor receptor (EFGR) oncogenic pathway to predict response to EGFR-targeted monoclonal antibodies in metastatic colorectal cancer
Bianchi, A. S., Bencardino, K. B., Nicolantonio, F. D., Pozzi, F., Funaioli, C., Gambi, V., Arena, S., Martini, M., Lamba, S., Cassingena, A., et al. (2010) · Targeted Oncology · doi:10.1007/s11523-010-0138-5 · Cited by 31
Intestinal epithelial-specific PTEN inactivation results in tumor formation
Byun, D.-S., Ahmed, N., Nasser, S., Shin, J., Al-Obaidi, S. J., Goel, S., Corner, G. A., Wilson, A. J., Flanagan, D. J., Williams, D. S., et al. (2011) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00178.2011 · Cited by 31
Prognostic significance of PTEN expression in esophageal squamous cell carcinoma from Linzhou City, a high incidence area of northern China
Chang, D., Wang, T.-Y., Li, H., Wei, J.-C., & Song, J.-X. (2007) · Diseases of the Esophagus · doi:10.1111/j.1442-2050.2007.00695.x · Cited by 31
Targeting PTEN in Colorectal Cancers
Kotelevets, L., Scott, M. G. H., & Chastre, E. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-02771-1_5 · Cited by 31
The promise of mTOR inhibitors in the treatment of colorectal cancer
Kim, D.-D., & Eng, C. (2012) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2012.721353 · Cited by 31
Phospho-ERK and AKT status, but not KRAS mutation status, are associated with outcomes in rectal cancer treated with chemoradiotherapy
Davies, J. M., Trembath, D. G., Deal, A. M., Funkhouser, W. K., Calvo, B. F., Finnegan, T., Weck, K. E., Tepper, J. E., & O’Neil, B. H. (2011) · Radiation Oncology · doi:10.1186/1748-717x-6-114 · Cited by 30
The Insulin-like Growth Factor System and Colorectal Cancer
Gligorijević, N., Dobrijević, Z., Šunderić, M., Robajac, D., Četić, D., Penezić, A., Miljuš, G., & Nedić, O. (2022) · Life · doi:10.3390/life12081274 · Cited by 30
The path to metastatic mouse models of colorectal cancer
Romano, G., Chagani, S., & Kwong, L. N. (2018) · Oncogene · doi:10.1038/s41388-018-0155-x · Cited by 32
Genomics and proteomics—the way forward
Baak, J. P. A., Janssen, E. A. M., Søreide, K., & Heikkilæ, R. (2005) · Annals of Oncology · doi:10.1093/annonc/mdi728 · Cited by 30
Coalterations of p53 and PTEN tumor suppressor genes in non–small cell lung carcinoma patients
Andjelković, T., Banković, J., Stojšić, J. M., Milinković, V., Podolski-Renić, A., Ruždijić, S., & Tanić, N. (2010) · Translational research · doi:10.1016/j.trsl.2010.09.004 · Cited by 27
A rationale for mTOR inhibitors as chemoprevention agents in Peutz-Jeghers syndrome
Kuwada, S. K., & Burt, R. W. (2011) · Familial Cancer · doi:10.1007/s10689-011-9471-9 · Cited by 27
Therapeutic targeting of the phosphatidylinositol 3-kinase signaling pathway: novel targeted therapies and advances in the treatment of colorectal cancer
Yu, M., & Grady, W. M. (2012) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x12448456 · Cited by 26
PTEN Gene: A Model for Genetic Diseases in Dermatology
Romano, C., & Schepis, C. (2012) · The Scientific World JOURNAL · doi:10.1100/2012/252457 · Cited by 27
Altered PTEN function caused by deletion or gene disruption is associated with poor prognosis in rectal but not in colon cancer
Bohn, B. A., Mina, S., Krohn, A., Simon, R., Kluth, M., Harasimowicz, S., Quaas, A., Bockhorn, M., Izbicki, J. R., Sauter, G., et al. (2013) · Human Pathology · doi:10.1016/j.humpath.2012.12.006 · Cited by 25
Histone Acetyltransferase (HAT) P300/CBP Inhibitors Induce Synthetic Lethality in PTEN-Deficient Colorectal Cancer Cells through Destabilizing AKT
Liu, Y., Yang, E. J., Shi, C., Mou, P. K., Zhang, B., Wu, C., Lyu, J., & Shim, J. S. (2020) · International Journal of Biological Sciences · doi:10.7150/ijbs.42197 · Cited by 25
Relationship Between Colorectal Cancer Biomarkers and Response to Epidermal Growth Factor Receptor Monoclonal Antibodies
Hawkes, E. A., & Cunningham, D. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.29.5626 · Cited by 25
The Role of Akt Pathway Signaling in Glucose Metabolism and Metabolic Oxidative Stress
Simons, A. L., Orcutt, K. P., Madsen, J. M., Scarbrough, P. M., & Spitz, D. R. (2011) · Humana Press eBooks · doi:10.1007/978-1-61779-397-4_2 · Cited by 26
PTEN mRNA expression is less pronounced in left- than right-sided colon cancer: a retrospective observational study
Kuramochi, H., Nakamura, A., Nakajima, G., Kaneko, Y., Araida, T., Yamamoto, M., & Hayashi, K. (2016) · BMC Cancer · doi:10.1186/s12885-016-2400-4 · Cited by 23
PTEN deletion drives aberrations of DNA methylome and transcriptome in different stages of prostate cancer
Wang, C., Feng, Y., Zhang, C., Cheng, D., Wu, R., Yang, Y., Sargsyan, D., Kumar, D., & Kong, A. T. (2019) · The FASEB Journal · doi:10.1096/fj.201901205rr · Cited by 23
Class IA phosphoinositide 3-kinase isoforms and human tumorigenesis: implications for cancer drug discovery and development
Wee, S., Lengauer, C., & Wiederschain, D. (2008) · Current Opinion in Oncology · doi:10.1097/cco.0b013e3282f3111e · Cited by 22
Genetic unraveling of colorectal cancer
Rasool, S., Rasool, V., Naqvi, T., Ganai, B. A., & Shah, B. A. (2014) · Tumor Biology · doi:10.1007/s13277-014-1713-7 · Cited by 25
Personalized treatment for advanced colorectal cancer: KRAS and beyond
Karapetis, C. S., & Patel, G. S. (2013) · Cancer Management and Research · doi:10.2147/cmar.s35025 · Cited by 20
Association of promoter methylation and 32-bp deletion of the PTEN gene with susceptibility to metabolic syndrome
Hashemi, M. M., Rezaei, H., Eskandari‐Nasab, E., Kaykhaei, M. A., & Taheri, M. (2012) · Molecular Medicine Reports · doi:10.3892/mmr.2012.1174 · Cited by 21
Novel Drugs Targeting the Epidermal Growth Factor Receptor and Its Downstream Pathways in the Treatment of Colorectal Cancer: A Systematic Review
Merla, A., & Goel, S. (2012) · Chemotherapy Research and Practice · doi:10.1155/2012/387172 · Cited by 22
PTEN hamartoma tumour syndrome: what happens when there is no PTEN germline mutation?
Yehia, L., & Eng, C. (2020) · Human Molecular Genetics · doi:10.1093/hmg/ddaa127 · Cited by 21
PTEN deletion potentiates invasion of colorectal cancer spheroidal cells through 3D Matrigel
Chandrasekaran, S., Deng, H., & Ye, F. (2015) · Integrative Biology · doi:10.1039/c4ib00298a · Cited by 21
Epigenetic Downregulation of PTEN in Gallbladder Cancer
Tekcham, D. S., Gupta, S., Shrivastav, B. R., & Tiwari, P. K. (2017) · Journal of Gastrointestinal Cancer · doi:10.1007/s12029-017-9919-8 · Cited by 20
Cancer genomics: integrating form and function
Kim, S. Y., & Hahn, W. C. (2007) · Carcinogenesis · doi:10.1093/carcin/bgm086 · Cited by 21
Sclerosing Polycystic Adenoma: Conclusive Clinical and Molecular Evidence of Its Neoplastic Nature
Hernandez-Prera, J. C., Saeed‐Vafa, D., Heidarian, A., Gewandter, K. R., Otto, K. J., & Wenig, B. M. (2021) · Head and Neck Pathology · doi:10.1007/s12105-021-01374-w · Cited by 19
Molecular alterations of Ras‐Raf‐mitogen‐activated protein kinase and phosphatidylinositol 3‐kinase‐Akt signaling pathways in colorectal cancers from a tertiary hospital at Kuala Lumpur, Malaysia
Yip, W. K., Choo, C. W., Leong, V. C., Leong, P. P., Jabar, M. F., & Seow, H. F. (2013) · Apmis · doi:10.1111/apm.12152 · Cited by 20
Differential Antineoplastic Effects of Butyrate in Cells With and Without a Functioning DNA Mismatch Repair
Dronamraju, S. S., Coxhead, J. M., Kelly, S. B., & Mathers, J. C. (2009) · Nutrition and Cancer · doi:10.1080/01635580903191486 · Cited by 18
A study on promoter methylation of PTEN in sporadic breast cancer patients from North India
Siddiqui, S., Akhter, N., Deo, S. V. S., Shukla, N. K., & Husain, S. A. (2016) · Breast Cancer · doi:10.1007/s12282-015-0665-0 · Cited by 18
EPHA3 Contributes to Epigenetic Suppression of PTEN in Radioresistant Head and Neck Cancer
Kim, S., Kang, B. C., Seong, D., Lee, W.-H., An, J. H., Je, H.-U., Cha, H., Cha, H., Kim, S., Kim, S.-W., et al. (2021) · Biomolecules · doi:10.3390/biom11040599 · Cited by 18
The AP-2 transcription factor is required for the ganglioside GM3-stimulated transcriptional regulation of a PTEN gene
Choi, H., Chung, T., Kim, S. J., Cho, S. Y., Lee, Y., Lee, Y., Ko, J. H., & Kim, C. (2008) · Glycobiology · doi:10.1093/glycob/cwn016 · Cited by 18
Overexpression of p101 activates PI3Kγ signaling in T cells and contributes to cell survival
Johnson, C., Marriott, S. J., & Levy, L. (2007) · Oncogene · doi:10.1038/sj.onc.1210504 · Cited by 18
Clinicopathologic and Molecular Analysis of a Choroidal Pigmented Schwannoma in the Context of a PTEN Hamartoma Tumor Syndrome
Venturini, G., Moulin, A., Deprez, M., Uffer, S., Bottani, A., Zografos, L., & Rivolta, C. (2012) · Ophthalmology · doi:10.1016/j.ophtha.2011.09.057 · Cited by 17
Clofarabine‑phytochemical combination exposures in CML cells inhibit DNA methylation machinery, upregulate tumor suppressor genes and promote caspase‑dependent apoptosis
Kaufman‐Szymczyk, A., Majda, K., Szuławska‐Mroczek, A., Fabianowska‐Majewska, K., & Lubecka, K. (2019) · Molecular Medicine Reports · doi:10.3892/mmr.2019.10619 · Cited by 17
Genomic variation as a marker of response to neoadjuvant therapy in locally advanced rectal cancer
Douglas, J. K., Callahan, R. E., Hothem, Z. A., Cousineau, C. S., Kawak, S., Thibodeau, B. J., Bergeron, S., Li, W., Peeples, C., & Wasvary, H. J. (2020) · Molecular & Cellular Oncology · doi:10.1080/23723556.2020.1716618 · Cited by 17
CRISPR/Cas9 in epigenetics studies of health and disease
Sar, P., & Dalai, S. K. (2021) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2021.01.022 · Cited by 18
PTEN, Longevity and Age-Related Diseases
Tait, I., Li, Y., & Lu, J. (2013) · Biomedicines · doi:10.3390/biomedicines1010017 · Cited by 17
Practical and Molecular Evaluation of Colorectal Cancer: New Roles for the Pathologist in the Era of Targeted Therapy
Hertogh, G. D., & Geboes, K. (2010) · Archives of Pathology & Laboratory Medicine · doi:10.5858/134.6.853 · Cited by 18
Oncogenèse colorectale
Laurent‐Puig, P., Agostini, J., & Maley, K. (2010) · Bulletin du Cancer · doi:10.1684/bdc.2010.1216 · Cited by 32
Assessment of Microsatellite Instability in Very Small Microdissected Samples and in Tumor Samples that are Contaminated With Normal DNA
Trusky, C. L., Sepulveda, A. R., & Hunt, J. L. (2006) · Diagnostic Molecular Pathology · doi:10.1097/00019606-200606000-00001 · Cited by 16
Expression of PTEN and phosphorylated Akt in human cholesteatoma epithelium
Yune, T. Y., & Byun, J. Y. (2008) · Acta Oto-Laryngologica · doi:10.1080/00016480802258802 · Cited by 15
PTEN deficiency confers colorectal cancer cell resistance to dual inhibitors of FLT3 and aurora kinase A
Liu, Y., Yang, E. J., Zhang, B., Miao, Z., Wu, C., Lyu, J., Tan, K., Poon, T. C. W., & Shim, J. S. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.08.011 · Cited by 15
Combined inhibition of Dnmt and mTOR signaling inhibits formation and growth of colorectal cancer
Zhang, Y., Zhao, S., Tian, X., Sun, D., Xiong, H., Dai, Q., Li, X., & Fang, J. (2009) · International Journal of Colorectal Disease · doi:10.1007/s00384-009-0664-8 · Cited by 15
RASSF1 and PTEN Promoter Hypermethylation Influences the Outcome in Epithelial Ovarian Cancer
Zuberi, M., Mir, R., Dholariya, S. J., Najar, I. A., Yadav, P., Javid, J., Guru, S. A., Mirza, M., Gandhi, G., Khurana, N., et al. (2014) · Clinical Ovarian and Other Gynecologic Cancer · doi:10.1016/j.cogc.2014.12.002 · Cited by 14
Estudio de patrones de metilación génica en tumores del tubo digestivo
Roa, J. C., Patricia García, M., Angélica Melo, A., Óscar Tapia, E., Miguel Villaseca, H., Araya, J. C., & Pablo Guzmán, G. (2008) · Revista médica de Chile · doi:10.4067/s0034-98872008000400005 · Cited by 14
Interplay between Epigenetics and Cellular Metabolism in Colorectal Cancer
Zhang, X., Dong, Z., & Cui, H. (2021) · Biomolecules · doi:10.3390/biom11101406 · Cited by 14
Precise Immunodetection of PTEN Protein in Human NeoplasiaPreprint
Pulido, R., Mingo, J., Gaafar, A., Nunes‐Xavier, C. E., Luna, S., Torices, L., Angulo, J. C., & Lopez, J. I. (2019) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a036293 · Cited by 14

Authors: Goel, A., Arnold, C. N., Niedzwiecki, D., Carethers, J. M., Dowell, J. M., Wasserman, L., Compton, C., Mayer, R. J., Bertagnolli, M. M., & Boland, C. R.
Affiliations: University of California San Diego (US)
Duke University (US)
McGill University (CA)
Dana-Farber Cancer Institute (US)
Brigham and Women's Hospital (US)
United States Department of Veterans Affairs (US)
ORCID: Goel, Ajay
Arnold, Christian N.
Niedzwiecki, Donna
Carethers, John M.
Compton, Carolyn
Mayer, Robert J.
Bertagnolli, Monica M.
Boland, C. Richard
Venue: Cancer Research
Publisher: American Association for Cancer Research (AACR)
Published: 2004-05-01
Volume: 64
Issue: 9
Pages: 3014-3021
ISSN: 0008-5472 (ISSN-L)
1538-7445
DOI: 10.1158/0008-5472.can-2401-2
OpenAlex: W2054894450
Cited by: 302
References: 35
Citations by year: 2026: 2 · 2025: 3 · 2024: 8 · 2023: 12 · 2022: 9 · 2021: 11 · 2020: 12 · 2019: 12 · 2018: 13 · 2017: 5 · 2016: 12 · 2015: 19 · 2014: 17 · 2013: 27 · 2012: 30
FWCI: 10.72
Type: journal article
Language: en
Open access: closed
Locations: Cancer Research (publishedVersion)
PubMed (publishedVersion)
FreiDok plus (Universitätsbibliothek Freiburg) (submittedVersion)
Funders: University of California, San Diego
National Cancer Institute (R01-CA-72851, R01CA072851, R01 CA90231, R01CA090231, U10CA031946, CA-31946)
Topics: Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
Health Sciences › Medicine › Oncology › Colorectal Cancer Treatments and Studies
Keywords: PTEN, promoter hypermethylation, microsatellite instability, sporadic colorectal cancer, tumor suppressor inactivation, PTEN mutation, PTEN protein expression, genomic instability, second hit, DNA methylation
MeSH terms: Aged, Alleles, Chromosomes, Human, Pair 10, Female, Humans, Male, Middle Aged, Mutation, Phosphoric Monoester Hydrolases, Promoter Regions, Genetic, Colorectal Neoplasms, Gene Expression Regulation, Neoplastic, Microsatellite Repeats, DNA Methylation, Loss of Heterozygosity, Gene Silencing, Tumor Suppressor Proteins, PTEN Phosphohydrolase

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Frequent Inactivation of PTEN by Promoter Hypermethylation in Microsatellite Instability-High Sporadic Colorectal Cancers

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks